William Beaumont University Hospital Pharmacy Residency Programs

The purpose of the ASHP-accredited Corewell Health William Beaumont University Hospital post-graduate year one (PGY1) pharmacy residency is to build on doctor of pharmacy (Pharm.D.) education and outcomes to contribute to the development of clinical pharmacists responsible for medication-related care of patients with a wide range of conditions, eligible for board certification, and eligible for postgraduate year two (PGY2) pharmacy residency training.

The PGY1 residency program at Corewell Health William Beaumont University Hospital will foster the development of competent and confident pharmacists. As a member of the health care team, residents will be responsible for providing direct patient care to multiple populations. They will exercise skill in educating health care professionals and patients on medication related topics. Residents will solve practice-related problems in a time sensitive manner through critical thinking skills. Residents will demonstrate professional maturity by following a personal philosophy of practice, monitoring their own performance, exhibiting commitment to the profession and exercising leadership in improving the safety of the medication use system. Lastly, residents will possess the knowledge and leadership skills to promote the advancement of the practice of pharmacy.

• Core structure: individualized learning experiences, clinical and operational staffing and longitudinal requirements
• Individualized resident development plan to accomplish both program and resident-identified goals

• Advisor program where each resident selects an advisor for the year
• Opportunity to participate in a teaching certificate program
• Chief resident and other chair positions available
• Early commit option for PGY2 resident positions in ambulatory care, critical care, infectious diseases
  • A PGY2 position in emergency medicine and PGY1/PGY2 HSPAL combined program are also available through the traditional match process
• Leadership and preceptor development opportunities
• Research training program
• In-house on-call service

The 54 week long residency program is divided into eleven one-month experiences following a month and a half orientation dedicated to operational areas and clinical services.  Refer to the "rotations" section for required, selective, and elective learning experiences. PGY1 Residents at Corewell Health William Beaumont University are also required to complete a number of longitudinal requirements.

• Complete all scheduled pharmacy Noon Conference presentations (2)
  • Journal Club, given on Drug Information (1)
  • Clinical presentation (1)
• Deliver Royal Oak Pharmacy Grand Rounds (PGR) (1)
• Develop and deliver a one-hour accredited CE presentation
• Prepare or revise a drug class review, monograph, treatment guideline, treatment protocol, utilization management criteria, and/or order set
• Present MUE research project at a regional resident research conference
• Submit new project idea to Residency Project Subcommittee
• Complete final MUE research project manuscript with submission to and approval of Residency Project Subcommittee (final score of SP or ACH)  
• Obtain and/or maintain Basic Life Support (BLS) and Advanced Cardiac Life Support (ACLS) certification for the duration of residency
• Complete the on-call service requirements (score of SP or ACH on all objectives in final On-Call Learning Experience evaluation)
• Attend the following required meetings:  
  • Traditional PGY: Fall MPA/MSHP Meeting, ASHP Midyear Clinical Meeting, regional resident research conference
• Upload all pertinent residency documents to “Files” tab in PharmAcademic (see Appendix I for list of documents)
• Completion of all deliverables
• No objectives with final score of Needs Improvement (NI)
• A mark of Achieved for Residency (ACHR) on ≥ 90% of program objectives (minimum of 28 of 31 objectives) 

• Attend the Michigan Society of Health System Pharmacists annual meeting

• Present at the ASHP midyear clinical meeting *
• Present at a regional pharmacy residency conference *

*Approved financial support for travel to conferences is at the discretion of the organization.

The PGY1 residency program at Corewell Health William Beaumont University Hospital consists of seven required learning experiences, at least one selective learning experience, up to three elective learning experiences, and several required longitudinal learning experiences. Residents may repeat any learning experience as an elective (with the exception of orientation and internal medicine). December is a dedicated project month. The current required, selective, elective, and longitudinal learning experiences are outlined below:

• Continuing education lecture
• Medication use evaluation (MUE) research project
• On-call program
• Staffing

• Adjunctive Therapy of Gabapentin in Alcohol Withdrawal Syndrome
• Comparative Analysis of Fixed versus Variable Dosing of Regional Citrate Anticoagulation in Critically Ill Patients on Continuous Kidney Replacement Therapy  
• Impact of preprocedural sodium-glucose cotransporter-2 inhibitor hold time on the incidence of adverse effects  
• Evaluation of Argatroban INR Elevation and Transition to Warfarin in Acute HIT
• Efficacy and Safety of IV Heparin Protocol for Acute VTE in Obese Patients
• Four Factor Prothrombin Complex Concentrate (4FPCC) versus Activated 4PCC for Acute Direct Xa Inhibitor Bleeding
• Inpatient Use of SGLT2 inhibitors and Effect on Heart Failure
• Evaluation of Glucose Management in Patients Undergoing Cardiac Surgery
• Impact of Early Administration of Long-Acting Insulin in Diabetic Ketoacidosis
• Safety and Efficacy of Early Antibiotic Discontinuation in Febrile Neutropenic Patients with Fever of Unknown Origin 
• Levetiracetam for Seizures Prophylaxis in Spontaneous Intracerebral Hemorrhage
• Evaluation of Hydrocortisone Dosing in the Management of Septic Shock in Adults 
• Safety and Efficacy of Digoxin Loading Doses in Renal Insufficiency 
• Impact of Staphylococcus aureus Nasal Screening on Antimicrobial Therapy in Non-Purulent Skin and Soft Tissue Infections
• Antimicrobial Prescribing Practices from Hospital to Home for Community Acquired Pneumonia (CAP) and Urinary Tract Infection (UTI)
• Continuous Infusion Ketamine for Sedation in Mechanically Ventilated COVID-19 Patients
• Metoprolol vs. Diltiazem in Heart Failure Patients with Atrial Fibrillation with Rapid Ventricular Response
• Impact of Pharmacist-Initiated Lithium Counseling on Lithium Toxicity and Retention of Knowledge about Lithium
• Impact of Daily Pharmacist Review of Antimicrobial Agent Dosing in Continuous Renal Replacement Therapy
• The impact of switching from trough-guided to AUC guided vancomycin dosing on hospital resources
• Evaluation of the efficacy and safety of warfarin vs. DOACs after bioprosthetic valve replacement
• Comparison of argatroban vs. heparin for VV-ECMO anticoagulation and the impact on patient outcomes and safety
• De-escalation of empiric vancomycin for pneumonia driven by pharmacist ordering of MRSA nasal screen
• Impact of MRSA PCR assay and MRSA nasal culture on de-escalation of empiric vancomycin therapy for pneumonia
• Risk factors for high-dose methotrexate-induced nephrotoxicity in the treatment of hematologic malignancies
• Evaluation of cephalexin for treatment of acute uncomplicated cystitis in patients discharged home from the emergency department
• Evaluating the Effectiveness of Oral Antibiotics for Definitive Treatment of Enterobacteriaceae Associated Bloodstream Infections
• Characterizing medical residents’ opioid prescribing patterns before and after the implementation of new opioid laws
• Assessing Oral Anticoagulation after an Acute Ischemic Stroke
• Evaluating Antipsychotic Use for ICU Delirium in an Academic Medical Center
• Assessing Adherence to the Medication Components of the Severe Sepsis 3 and 6 – hour Resuscitation Bundle for the Treatment of Sepsis, Severe Sepsis, and Septic Shock
• Comparing Catheter-Directed Alteplase vs. Systemic Alteplase 100mg v. Systemic Alteplase 50mg Associated Bleeds
• Apixaban Major Bleeding in Atrial Fibrillation:  Patient Characteristics, Management and Outcomes
• Clinical and Economic Outcomes of Warfarin Versus Direct Oral Anticoagulants (DOACs) Following Alteplase for the Treatment of Pulmonary Embolism (PE)
• Hemodynamic Effects of Dexmedetomidine Compared to Propofol in Critically Ill Adults
• Evaluation of De-Escalation of Empirically Initiated Broad-Spectrum Antibiotics in Patients Diagnosed with Healthcare-Associated Pneumonia
• Evaluation of Compliance to an Intravenous Insulin Infusion Protocol in the Management of Diabetic Ketoacidosis
• Evaluation of Specialty Pharmacy Services and Treatment Outcomes for Hepatitis C at a Large Academic Medical Center
• An Economic Evaluation Comparing Three Different Regimens (Moxifloxacin vs. Levofloxacin vs. Ceftriaxone/Azithromycin) for the Treatment of Community Acquired Pneumonia
• Development, Optimization and Implementation of Trigger Tool Methodology to Improve Identification of Adverse Medication Events
• Safety and Efficacy of Early Antibiotic Discontinuation in Febrile Neutropenic Patients with Fever of Uknown Origin
• Impact of Early Administration of Long-Acting Insulin in Diabetic Ketoacidosis
• Inpatient Use of Sodium-Glucose Cotransporter-2 Inhibitors and the Effect on Heart Failure
• Evaluation of Glucose Management in Patients Undergoing Cardiac Surgery

NOTE: Corewell Health has multiple residency programs. The traditional PGY1 program based at Corewell Health William Beaumont University Hospital is listed as ASHP program #43600 in the online ASHP Residency Directory. Please ensure you are applying to the desired program. 

Residency candidates must be a graduate of a college of pharmacy accredited in the U.S. and must be eligible for licensure in the State of Michigan. Candidates must also register for the Matching Program and have a National Matching Services (NMS) applicant number.

Interested candidates must submit the following materials via PhORCAS:

• Curriculum vitae
• Letter of intent
• Three letters of recommendation (letters from at least 2 clinical preceptors preferred)
• Transcripts from college of pharmacy

All application materials must be received by January 2, 2026.

Direct any questions about the PGY1 residency program to:

Allycia Marie, Pharm.D
Clinical pharmacy specialist, critical care
PGY1 residency program director
Corewell Health William Beaumont University Hospital
Department of Pharmaceutical Services
3601 West 13 Mile Rd.,
Royal Oak, MI 48073
Phone: 248.898.5878
Fax: 248.898.4046

The Health-System Pharmacy Administration & Leadership (HSPAL) residency program is designed for our residents to develop the knowledge, skills, and abilities needed for success as a pharmacy leader. The two-year HSPAL residency strives to meet the needs of the resident based on candidate interests and individual goals alongside a combination of required monthly and concurrent longitudinal rotations to provide a robust training program. Residents will have the opportunity to function as valued members of health care teams and will build leadership experience utilizing knowledge and experience gained in operations and clinical services.

Upon completion of the program, residents will have developed the clinical acumen, business knowledge, and professional skills required to become an effective pharmacy leader in any health care organization. The first year is designed to provide a strong clinical foundation with a variety of clinical and non-patient care learning experiences. The second year builds upon the success of the first and provides exposure to managers and leaders in the pharmacy enterprise in financial, medication safety, operational, and clinical management experiences. Graduates of the program will receive a PGY-1 Pharmacy Residency certificate and a PGY-2 Health-System Pharmacy Administration and Leadership Residency certificate.

For specifics on the PGY1 component of the program, please review the PGY1 Pharmacy tab.  Successful completion of the PGY1 Pharmacy Residency is required before moving to the PGY2 HSPAL Residency. 

Requirements for Successful Completion of the PGY2 HSPAL Residency 

• Present a leadership topic at the Preceptor & Leadership Development series 
• Attend and participate in Corewell Health Leadership Development Curriculum 
• Develop and deliver a one-hour accredited CE presentation  
• Prepare or revise a drug class review, monograph, treatment guideline, treatment protocol, utilization management criteria, and/or order set  
• Present research project at ASHP Midyear Clinical Meeting 
• Complete research project with manuscript  
• Complete staffing and administrator on-call requirement 
• Upload all pertinent residency documents to “files” tab in PharmAcademic  
• No objectives with a final score of Needs Improvement (NI) 
• A mark of Achieved for Residency (ACHR) on ≥ 90% of program objectives (minimum of 28 of 31 objectives)  
• The following meeting(s) are required for the resident(s) to attend:  
  • Fall MPA/MSHP Meeting 
  • ASHP Midyear Clinical Meeting 

• The following meeting(s) are optional for the resident(s) to attend: 
  • ASHP Conference for Pharmacy Leaders

PGY1 Learning Experiences – Please review the PGY1 Pharmacy tab 

PGY2 Learning Experiences 

• Orientation 
• Business Services 
• Clinical Pharmacy Management 
• Direct Supervision 
• Pharmacy Informatics 
• Pharmacy Operations - Academic Medical Center 
• Pharmacy Operations - Community Hospital 
• Pharmacy Supply Chain Management  

• Critical care - 2 (different population)
• Emergency medicine
• Infectious diseases consult service
• Nutrition support
• Inpatient hematology/oncology
• Solid organ transplant

• Compounding Management & Compliance 
• Home Infusion Management 
• Managed Care 
• Medication Safety 
• Pediatric Management 
• Pharmacy Executive Leadership 
• Pharmacy Training & Education Management 
• Specialty & Retail Pharmacy Management  

• Committee Involvement 
• Continuing Education Presentation 
• Human Resource Management 
• Manager On Call 
• Medication Safety 
• Research Project 
• Staffing (every 3rd weekend)  

• Lead Pharmacist and Administrator on-call rotation every 3rd weekend staffing  

• Business services
• Clinical pharmacy management
• Direct supervision
• Pharmacy informatics
• Pharmacy operations – academic medical center
• Pharmacy operations – community hospital
• Pharmacy supply chain management 

• Ambulatory care management
• Compounding management and compliance
• Home infusion management
• Managed care
• Medication safety
• Pediatric management
• Pharmacy training and education management
• Specialty and retail pharmacy management 

• Committee involvement
• Continuing education
• Human resource management
• Manager on-call
• Medication safety
• Research project
• Staffing 

• ASHP Clinical Midyear Meeting  
• MHSP Annual Meeting  
• Annual Residency Conference  

• Every 3rd weekend as the central lead pharmacist

• Licensed pharmacist or eligible for licensure in the State of Michigan (including controlled substance license) 

University Hospital is listed as ASHP program #43016 in the online ASHP residency directory. Please ensure you are applying to the desired program.

Residency candidates must be a graduate of a College of Pharmacy accredited in the U.S. and must be eligible for licensure in the State of Michigan. Candidates must also register for the Matching Program and have a National Matching Services (NMS) applicant number.

Interested candidates must submit the following materials via Pharmacy Online Residency Centralized Application Service (PhORCAS):

• Curriculum vitae
• Letter of intent
• Three letters of recommendation (letters from at least 2 clinical preceptors preferred)
• Transcripts from College of Pharmacy

Direct any questions about the PGY1/PGY2 Health-System Pharmacy Administration & Leadership Residency to:  

Richard Taylor, PharmD, MBA 
Director of Pharmacy 
Program Director - PGY1/PGY2 Health-System Pharmacy Administration & Leadership Residency  
Corewell Health William Beaumont University Hospital 
3601 West 13 Mile Road 
Royal Oak, MI 48073  

Brendan Bectel, PharmD, MBA 
PGY2 Health-System Pharmacy Administration & Leadership Resident 
Corewell Health William Beaumont University Hospital 
3601 West 13 Mile Road 
Royal Oak, MI 48073  

Corewell Health William Beaumont University Hospital offers a twelve-month American Society of Health-System Pharmacists (ASHP) accredited, ambulatory care PGY-2 residency program for one residency candidate. The goals, objectives, and evaluation procedures are established to be consistent with the PGY2 ASHP Standards with ASHP Goals and Objectives focused in ambulatory care. The program allows flexibility to adapt to the needs and interests of the individual resident, while providing a foundation to develop professional ambulatory care practice skills. The program begins on approximately July 1 and is at a minimum 52 weeks in duration.

PGY2 purpose: PGY2 pharmacy residency programs build on doctor of pharmacy (PharmD) education and PGY1 pharmacy residency training to develop pharmacist practitioners with knowledge, skills, and abilities as defined in the educational competency areas, goals, and objectives for advanced practice areas. Residents who successfully complete PGY2 residency programs are prepared for advanced patient care or other specialized positions, along with board certification in the advanced practice area, if available.

Residency description: The PGY2 ambulatory care pharmacy residency at Corewell Health William Beaumont University Hospital provides comprehensive training across diverse areas of ambulatory care. Through a combination of required and elective rotations the resident will develop advanced clinical expertise in ambulatory care pharmacotherapy while strengthening leadership abilities within a multidisciplinary care environment. The program emphasizes effective communication through collaboration with various healthcare providers and patients, and the delivery of both formal and informal presentations. Teaching and precepting skills are fostered through involvement in the layered learning model with pharmacy students and PGY1 residents.

Residents will take full responsibility for the care of each patient served. Residents will provide necessary education for both medical professionals practicing in the outpatient clinic as well as all patients treated. All pharmacotherapy and disease state issues will be addressed and resolved while taking into account potential barriers in the implementation of the pharmacotherapy plan (i.e., patients' socioeconomic status, insurance status, and/or cultural barriers). Residents will practice pharmacy and communicate with other healthcare professionals in a manner that displays commitment to the profession and importance of a clinical specialist in the outpatient setting.

Overview of program requirements: The PGY-2 ambulatory care resident must meet the requirements for employment at Corewell Health as well as: 

• Licensed pharmacist or eligible for licensure in the State of Michigan (including controlled substance license) 
• Applicants must have completed an ASHP-accredited or candidate-status PGY1 residency by the program start date 

Criteria for Certificate: 

• Complete all scheduled pharmacy noon conference presentations (2) 
• Complete scheduled physician or nursing in-services (1) 
• Develop and deliver a one-hour accredited CE presentation 
• Develop and deliver scheduled ambulatory department meeting journal clubs (2) 
• Update and maintain resident development plan on quarterly basis   
• Upload all pertinent residency documents to SharePoint and PharmAcademic 
• Complete the transitions of care- service requirement 
• Attend the following required meetings: ASHP Midyear Clinical Meeting, regional resident research conference 
• Presentation of residency research project at regional pharmacy residency conference 
• Submission of new project idea to residency project subcommittee 
• Approval by residency project subcommittee of final research manuscript 
• Participate in health care related community outreach events throughout the year as determined by RPD (4) 
• Tracking of appendix topics completed (quarterly) 
• No objectives with a final score of “needs improvement” 
• A mark of ACHR on ≥ 90% of program objective 
• Maintain BLS certification throughout residency 
• *Program requirements are subject to change at the discretion of the residency program director and advisory committee.

The PGY-2 ambulatory care residency program strives to meet the needs of the resident based on previous PGY-1 residency experience, interests, and individual goals of the candidate. The residency program is divided into four 3-month blocks, with the first block devoted to orientation to the diabetes, outpatient clinic anticoagulation service, high-risk OB, pharmacist, and discharge transition clinics (orientation-outpatient clinics). This allows the resident to establish a presence and build a rapport with the nursing and physician staff as well as with patients of the outpatient clinic.

Based on resident’s interest and individual training plan, the resident can choose up to 2 elective learning experiences during the 2nd, 3rd, and 4th quarters. All elective experiences are longitudinal. The resident will maintain a longitudinal practice in the core longitudinal clinics (diabetes, outpatient clinic anticoagulation service, internal medicine, and discharge transition clinics) as well as the core pharmacist clinic. 

The sequence of learning experiences is dependent upon preceptor availability. 

• Orientation - Outpatient clinics (longitudinal - 3 month experience)
• Core longitudinal clinics (longitudinal - 9 month experience)
  • Outpatient clinic anticoagulation service
  • Diabetes clinic
  • Discharge transition clinic
  • Internal medicine clinic
• Core pharmacist clinic (longitudinal - 9 month experience)
• Ambulatory pharmacy administration (longitudinal - 9 month experience)
• Research 1, 2, 3, and 4 (sequential longitudinal - 3 month experiences)
• Continuing education program
• Transitions of care - service requirement (longitudinal - 12 month experience)

• Academics (longitudinal - 3 month experience)
• Advanced pharmacy informatics (longitudinal- 3 month experience)
• Cardiology (longitudinal- 3-month experience) 
• Infectious disease clinic (longitudinal - 3 month experience) 
• Pediatric ambulatory care (neurology) (longitudinal-3 month experience)
• Primary care- value based clinic (longitudinal- 3 month experience)
• Specialty pharmacy (longitudinal - 3 month experience) 
• High-risk OB (longitudinal - 3 month experience)
• Patient care lab (longitudinal - 3 month experience)
• Family medicine (longitudinal - 3 month experience) 

2025

Min Ji Park, PharmD 
First position after residency: Pharmacy specialist in anticoagulation, Christiana Care, Delaware

2024

Alanah Bratley, PharmD, BCACP 
First position after residency: Ambulatory care clinical specialist, Henry Ford Health Systems, Michigan

2023

Chelsea Dezfuli, PharmD, BCACP
First position after residency: Ambulatory care pharmacy specialist, Yale New Haven, Connecticut

2022

Randi Katz, PharmD, BCACP, BCPS 
First position after residency: Ambulatory care pharmacist, Henry Ford Genesys, Michigan

2021

Patricia Lee, PharmD, BCACP 
First position after residency: Ambulatory care clinical specialist, Henry Ford Health Systems, Michigan

2020

Bianca Mayzel, PharmD, BCACP 
First position after residency: Ambulatory care pharmacist internal medicine, Cleveland Clinic, Ohio

2019

Kaylin Braekevelt, PharmD , BCACP
First position after residency: Clinical pharmacist, Blue Cross Blue Shield of Michigan, Michigan

2018

Katie Kish, PharmD, BCACP 
First position after residency: Primary care clinical pharmacy specialist, Cleveland Clinic, Ohio  

2017

Whitney Aultman, PharmD, BCACP 
First position after residency: Ambulatory care clinical pharmacist with State of Franklin Healthcare Associates and assistant professor with East Tennessee State University Bill Gatton College of Pharmacy, Tennessee  

2016

Nadia Aneese, PharmD, BCACP 
First position after residency: Ambulatory care clinical specialist, Corewell Sterling Heights Family Medicine Center, Michigan  

2015

Jenny Lin (Leung), PharmD, BCACP
First position after residency: Ambulatory care clinical specialist, Henry Ford Health System, Michigan  

2014

Adina Feng, PharmD, BCACP 
First position after residency:  Ambulatory care clinical specialist, Henry Ford Health System, Michigan

2013

Elaine Ng, PharmD, BCACP 
First position after residency:  Anticoagulation specialist, Northshore University Health System, Illinois

2012

Jiz Thomas, PharmD, BCACP 
First position after residency:  Pharmacist, INMED Program, Honduras

2011

Holly Chiu, PharmD, BCACP 
First position after residency:  Ambulatory care clinical specialist, Beaumont Hospital, Royal Oak, Michigan  

2010

Deborah Virant-Young, PharmD, BCACP 
First position after residency:  Assistant clinical professor of pharmacology and toxicology, Michigan State University, College of Osteopathic Medicine, Michigan  

2009

Kristina Rowley, PharmD, BCACP, CDCES
First position after residency:  Assistant professor-Ferris State University with a clinical appointment at Michigan State University/Kalamazoo Center for Medical Studies, Michigan

2007

Ericka Ridgeway, PharmD, BCACP, CDCES 
First position after residency:  Ambulatory care clinical specialist, Trinity Health Oakland, Michigan

2002

Colleen Lauster, PharmD, BCPS, CDCES 
First position after residency:  Clinical specialist, internal medicine, Beaumont Hospital, Royal Oak, Michigan

2001

Sarah Muench, PharmD, BCACP, CDCES 
First position after residency:  Clinical specialist, ambulatory care, Beaumont Hospital, Royal Oak, Michigan 

Residency candidates must be a graduate of a college of pharmacy accredited in the United States and must be eligible for licensure in the State of Michigan. Candidates must have successfully completed an ASHP accredited PGY-1 residency. In addition, candidates must register for the ASHP Matching Program and have a National Matching Services (NMS) applicant number.

Interested candidates must submit the following information via Pharmacy Online Residency Centralized Application Service (PhORCAS):

Deadline for applications: January 5, 2026.

Completed residency packets will be reviewed. Upon favorable review, residency candidates will be contacted to schedule an interview.

Sarah Muench, PharmD, BCACP, CDCES 
Clinical pharmacy specialist, ambulatory care 
Residency program director, PGY2 ambulatory care 
Phone: 248.551.7594 
Fax: 248.898.4046

Crissanne “Sunny” Abadir, PharmD
PGY2 Ambulatory Care resident 
Phone: 248.551.7594 
Fax: 248.898.4046 

Purpose  

PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available. 

The PGY2 critical care pharmacy residency program is at a minimum of 52 weeks in duration and begins with a month of orientation dedicated to training in operational areas and clinical services. Residency start date is approximately July 1. The program can be structurally divided into 3 components: individual learning experiences, longitudinal requirements, and weekend staffing. Non-longitudinal learning experiences are generally one calendar month in duration. Adjustments to rotation lengths may be made at the discretion of the Residency Program Director to individualize the resident’s training plan. Learning experience start and end dates will be documented in PharmAcademic. 

The PGY2 critical care pharmacy resident will complete 10 required learning experiences and 2 elective learning experiences. Any required or elective learning experience may be repeated a second time as an elective. The sequence of learning experiences is dependent upon preceptor availability and resident requests for learning experiences prior to midyear clinical meeting.   

Program requirements  

The resident must meet the following requirements for employment at Corewell Health as the PGY-2 critical care resident: 

• Applications are accepted via PhORCAS. All candidates must register with the National Matching Service (NMS) and have an NMS applicant number unless participating in the established early commit program.  
• Applicants to this program must be eligible for Michigan licensure, and a graduate of an ACPE accredited school/college of pharmacy (or one in process of pursuing accreditation) or have a Foreign Pharmacy Graduate Equivalency Committee (FPGEC) certificate from the National Association of Boards of Pharmacy (NABP).  
• Applicants must have completed an ASHP-accredited or candidate-status PGY1 residency by the program start date.  
• BLS and ACLS certification is required to be maintained throughout residency

*SICU ICU rotations include an ICU in each of the following:  

• Neuro/Trauma 
• General Surgery, ECMO, Transplant 
• Cardiovascular Surgery  

Orientation will take place during the month of July. The resident will spend time orienting to Corewell Health System and the department of pharmacy. Time will be spent with both pharmacy staff and specialists. The resident will be provided training in the use of the department’s computer system (EPIC), staffing on 6CN satellite, the dosing service, and other duties necessary to function as a pharmacist and a resident within the department.

The medical critical care rotation is a required learning experience for the critical care resident. This rotation is completed on the medical intensive care unit, and at least two MICU rotations are required for the critical care resident during the residency year. The overall goal of this rotation is to develop the resident’s skills in identifying and resolving drug-related problems in the critically ill using evidence-based primary literature in the area of critical care therapeutics. The resident will become the lead pharmacist on the medical intensive care unit team, and will assume all responsibilities of the rounding pharmacist. Residents may be involved in precepting doctor of pharmacy students, baccalaureate pharmacy students, or pharmacy practice residents.  

This surgical critical care rotation is one of three possible rotations available to meet the required two SICU rotations during the residency year. The rotation focuses on providing pharmaceutical care to the patients on 3 East, a 20-bed unit caring for patients from a variety of surgery services including: transplant surgery, general surgery, vascular surgery, thoracic surgery and others.  All patients undergoing renal & hepatic transplants are cared for on this unit post-operatively. The resident will participate in daily multidisciplinary rounds and will identify and resolve actual and potential drug related problems in the SICU. The resident will be responsible for all pharmacokinetic dosing and precepting graduate pharmacy students or PGY-1 residents if applicable.  During the month, the resident will meet with the preceptor as needed to discuss patient cases, interventions, and therapeutic topics. The rotation allows the resident to promote adherence to institution-developed guidelines, pathways and algorithms for a variety of disease states and drugs. The resident will present one case presentation or topic discussion to the pharmacy staff as well as one inservice to the surgical residents.

This cardiac critical care rotation is an elective rotation for the PGY2 critical care resident. The rotation focuses on providing pharmaceutical care to the patients on 6 East, a 20-bed intensive care unit caring for patients with a variety of cardiovascular disease states.  Some of the most common admission diagnoses include: acute decompensated heart failure, acute coronary syndrome (ACS), cardiogenic shock, and various arrhythmias. The resident will participate in daily multidisciplinary rounds and work closely with the medical team to identify and resolve actual and potential drug-related problems in the CICU.  The resident will also be responsible for pharmacokinetic dosing and precepting of pharmacy students or PGY-1 residents, if applicable, and will meet with the preceptor regularly to discuss patient cases, interventions, and therapeutic topics. One case presentation or topic discussion to the pharmacy staff and at least one in-service to the medical team will be completed by the resident prior to rotation completion.

This surgical critical care rotation is one of three possible rotations available to meet the required two SICU rotations during the residency year. The rotation focuses on providing pharmaceutical care to the patients on 2 East, a 20-bed unit caring for patients from a variety of surgery services including: cardiothoracic surgery, general surgery, vascular surgery, thoracic surgery, and others. All cardiothoracic surgery patients are cared for peri-operatively on this unit. The resident will participate in daily multidisciplinary rounds and will identify and resolve actual and potential drug-related problems in the SICU. The resident will be responsible for all pharmacokinetic dosing and precepting graduate pharmacy students or PGY-1 residents if applicable. During the month, the resident will meet with the preceptor as needed to discuss patient cases, interventions and therapeutic topics. The rotation allows the resident to promote adherence to institution-developed guidelines, pathways, and algorithms for a variety of disease states and drugs. The resident will present one case presentation or topic discussion to the pharmacy staff as well as one in-service to the surgical residents.

This surgical critical care rotation is one of three possible rotations available to meet the required two SICU rotations during the residency year. The rotation focuses on providing pharmaceutical care to the patients on 5 East, a 20-bed unit caring for patients from a variety of surgery services including: neurosurgery, trauma surgery, general surgery, vascular surgery, thoracic surgery, and others. All major trauma and neurologic injury patients are cared for peri-operatively on this unit. The resident will participate in daily multidisciplinary rounds and will identify and resolve actual and potential drug-related problems in the SICU. The resident will be responsible for all pharmacokinetic dosing and precepting graduate pharmacy students or PGY-1 residents if applicable. During the month, the resident will meet with the preceptor as needed to discuss patient cases, interventions, and therapeutic topics. The rotation allows the resident to promote adherence to institution-developed guidelines, pathways, and algorithms for a variety of disease states and drugs. The resident will present one case presentation or topic discussion to the pharmacy staff as well as one in-service to the surgical residents.

The residency project research month is a mandatory learning experience for the PGY-2 resident and is usually completed during the month of December. The main goals of the residency research project are to provide the resident with experience in 1) conducting a complete research project, 2) giving a presentation at a regional pharmacy conference, and 3) preparing a manuscript for submission to a professional journal. Projects at Corewell Health Hospital, Royal Oak are chosen for their 1) relevance to the current practice of pharmacy, 2) ability to be completed during the residency year, and 3) impact on patient care. The resident will not only experience the process of project development, implementation, and analysis but to also see that all their hard work will be utilized to further patient care and/or advance the provision of pharmaceutical services.

Infectious diseases rotation is an elective learning experience for the PGY-2 resident, and will be rounding with the ID team providing recommendations that ensure safe and effective use of antimicrobials. The resident will be responsible for identifying and resolving drug related problems in the patients assigned to them. They will also become familiar with key articles in the infectious diseases literature and use primary literature to support their desired interventions when appropriate. Residents completing the rotation will have the understanding of microbiology, pharmacokinetics, and pharmacodynamics of antimicrobial therapy. Residents will also be expected to demonstrate excellent communication skills with the medical team and the pharmacy staff, and may have an active role in precepting doctor of pharmacy students concurrently on the ID rotation.

The nutrition support rotation is a required learning experience for the PGY-2 resident. The Nutrition Support Service (NSS) is a multi-disciplinary team of nurses, pharmacists, and physicians responsible for monitoring all adult total parenteral nutrition (TPN) patients which consists of a significant subset of surgical ICU patients. The PGY-2 resident will be the lead pharmacist responsible for ensuring optimized nutrition therapy by promoting safe and cost-effective use of parenteral and enteral nutrition and to minimize inherent complications. The resident will round with a member of the NSS team on a daily basis and attend formal rounds with the attending physician twice weekly. Residents may be involved in precepting doctor of pharmacy students, pharmacy practice residents, and dietetic interns.  

Transplant is a required learning experience for the PGY-2 resident. The multidisciplinary transplant team consists of a nurse practitioner, surgical residents, attending nephrologists, hepatologists, and surgeons, as well as inpatient and outpatient nurses. The pharmacy resident will work with the team to identify and resolve medication-related issues in patients with end-stage renal or hepatic disease and those with a history of a solid organ transplant. The resident will also assist in transitioning new transplant recipients to the outpatient clinic by providing medication-related counseling. In addition to daily laboratory value monitoring, chart reviews, and participation in team rounds, the resident will also conduct topic discussions, deliver case presentations, and perform educational reviews for the team. Additionally, the resident may gain teaching experience by co-precepting doctor of pharmacy students and/or PGY-1 residents.

The academics rotation is an elective learning experience for PGY-2 residents. Residents will spend their time between Corewell Health Hospital and the Eugene Applebaum College of Pharmacy and Health Sciences (EACPHS) located in Detroit, MI. The rotation is structured to provide residents with insight into academia as a potential career path. Residents will gain an understanding of the different philosophies of teaching and pedagogy, the different types of faculty positions, the infrastructure of an academic program/college, and challenges facing academia. The preceptor will meet with residents prior to the rotation in order to gauge resident interest in different opportunities which may be available. The rotation activities list will be individualized and finalized after this meeting occurs. The resident must devise efficient strategies for accomplishing the required activities. When there is a doctor of pharmacy student on the rotation concurrently, the resident will have an active role in precepting the student and facilitate the topic discussions prepared by the student. 

Pediatric ICU is an elective patient care rotation for the PGY-2 resident. During this rotation the resident will be expected to be involved in all aspects of pharmacotherapy and to provide direct patient care for selected patients in the pediatric intensive care unit. The resident will work with the medical team to identify, present, and resolve medication therapy issues in the pediatric critical care setting. In addition, the PGY-2 resident will also be required to understand the operations within the pediatric pharmacy satellite, precept any pharmacy students on rotation, and provide education to pediatric pharmacy staff, pediatric ICU nursing staff, and the medical team. The resident may be asked to also complete a pediatrics/pediatric ICU related project during this rotation.

The neonatal ICU rotation is an elective patient care rotation for the PGY-2 resident. The resident will be involved in all aspects of pharmacotherapy and provide direct patient care for infants on the medical resident service in the neonatal intensive care unit. The resident will assume responsibilities of the rounding pharmacist and work with the medical team to identify, present, and resolve medication therapy issues for neonatal patients. In addition, the PGY-2 resident will also be required to understand the operations within the pediatric pharmacy satellite with regards to verifying and dispensing medications for neonatal patients as well as to provide education to the medical resident team and medical students.

The medication safety rotation is longitudinal learning experience for the PGY-2 resident. This rotation will provide residents the opportunity to gain experience with evaluation of both internally- and externally-identified sources of actual or potential medication safety concerns, action plan development, and implementation of system safety measures where applicable. There will be topic discussions throughout the year based on assigned readings, for which the resident is expected to be well-prepared. Residents may be actively involved in the monthly medication safety committee meeting throughout the year.

Lisa Hall Zimmerman, PharmD, BCPS, BCNSP, BCCCP, FCCM, FCCP 
Clinical pharmacist specialist | Surgical ICU – General Surgery, ECMO, transplant 
Program director, PGY2 critical care pharmacy residency 
Corewell Health William Beaumont University Hospital 
Department of pharmaceutical services 
3601 West 13 Mile Road 
Royal Oak, MI 48073 
Phone: 248.898.9219  

Purpose

The PGY2 emergency medicine pharmacy residency program at Corewell Health William Beaumont University Hospital consists of 12 months of emergency medicine and critical care training experiences. The PGY2 emergency medicine pharmacy residency program is accredited by the American Society of Health-System Pharmacists (ASHP). The goals, objectives, and evaluation procedures are established to be consistent with the PGY2 ASHP standards with ASHP goals and objectives focused in emergency medicine. The program allows flexibility to adapt to the needs and interests of the individual resident, while providing a foundation to develop professional emergency medicine practice skills.

PGY2 pharmacy residency programs build on doctor of pharmacy (PharmD) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

Program requirements

Overview of program requirements

The resident must meet the following requirements for employment at Corewell Health William Beaumont University Hospital as the PGY-2 emergency medicine resident:

• Licensed pharmacist or eligible for licensure in the State of Michigan (including controlled substance license)
• Successful completion of a PGY-1 ASHP accredited residency

 PGY2 emergency medicine pharmacy residency criteria for certificate

Below is a list of completed residency projects by past residents:

• 2021-2022
  • Comparative Analysis of One versus Two-Bag Methods for the Treatment of Adult Diabetic Ketoacidosis. Grant Morgan, Lisa Hall Zimmerman, Claudia Hanni, Elizabeth Cahill
• 2022-2023
  • Effectiveness and Safety of Two Alteplase Dosing Strategies for the Treatment of Pulmonary Embolism. Erika Waldsmith, Grant Morgan, Lisa Hall Zimmerman, Claudia Hanni, Jenna M. Holzhausen

• 2023-2024

  • Sepsis bundle compliance before and after implementation of a protocolized sepsis program. Rebecca Valean, Erika Waldsmith, Grant Morgan, Jenna Holzhausen, Lisa Hall Zimmerman
• 2024-2025

  • Hemodynamic Impact of Etomidate versus Ketamine for Rapid Sequence Intubation in Normotensive Patients. Austin Lake, Rebecca Valean, Grant Morgan, Lisa Hall Zimmerman 

• 2025-2026 
  • Labetalol vs Labetalol + Nicardipine for Hypertension in Acute Stroke Prior to Thrombolytic Therapy. Ezra Salifu, Austin, Lake, Grant Morgan, Lisa Hall Zimmerman    

The PGY-2 emergency medicine residency program strives to meet the needs of the resident based on previous PGY-1 residency experience, interests, and individual goals of the candidate.

Required learning experiences

• Emergency medicine – operations, adult medicine, antimicrobial stewardship I (1 month)
• Emergency medicine – adult medicine, antimicrobial stewardship II (1 month)
• Emergency medicine – critical care medicine I (1 month)
• Emergency medicine – critical care medicine II (1 month)
• Emergency medicine – general surgery / trauma (1 month)
• Emergency medicine – pediatric (1 month)
• Medical ICU (1 month)
• Surgical ICU (neuro/trauma) (1 month)
• Medical toxicology (1 month)
• Orientation/research (1 month)

Elective learning experiences

• Pediatric ICU (1 month)
• Infectious diseases (1 month)
• Cardiac ICU (1 month)

Required longitudinal learning experiences

• Longitudinal education (52 weeks)
  • Pharmacy noon conference presentation (2)
  • Emergency medicine grand rounds presentation (4)
  • Critical care/emergency medicine/infectious diseases journal club presentation (4)
  • Precepting PGY1 residents and pharmacy students
  • Simulation lab participation (monthly, as needed)
  • CE presentation – 1-hour seminar
• Longitudinal emergency medicine pharmacy service (52 weeks)
• Longitudinal leadership, committee, policy (52 weeks)
  • Committee involvement: stroke QAPI or sepsis (monthly)
  • Policy, procedure, or guideline update or development (1)
• Longitudinal pharmacy on call service (52 weeks)
• Longitudinal research I, research II, and manuscript (52 weeks)
  • Residency research I and II
  • Medication use evaluation (1)
  • Manuscript (1)

Residency candidates must be a graduate of a college of pharmacy accredited in the United States and must be eligible for licensure in the State of Michigan. Candidates must have successfully completed an ASHP accredited PGY-1 residency. In addition, candidates must register for the Matching Program and have a National Matching Services (NMS) applicant number.

Interested candidates must submit the following information via Pharmacy Online Residency Centralized Application Service (PhORCAS):

Deadline for applications: January 2nd.

Completed residency packets will be reviewed. Residency candidates will be contacted to schedule an interview

Grant Morgan, PharmD, BCPS, BCEMP
Clinical Pharmacist Specialist | Emergency Medicine
Program Director – PGY2 Emergency Medicine Pharmacy Residency
Corewell Health William Beaumont University Hospital
Department of Pharmaceutical Services
3601 West 13 Mile Road
Royal Oak, MI 48073
Phone: 248.898.9219 

Purpose

Corewell Health William Beaumont University Hospital offers an ASHP-accredited infectious diseases PGY2 residency program for one residency candidate. The program begins on approximately July 1 and is at a minimum 52 weeks in duration. 

The residency is tailored to the individual resident’s background, interests, and professional goals, offering flexibility while ensuring a strong foundation in infectious diseases and antimicrobial stewardship. Previous experience and identified strengths and areas for growth are considered when designing the resident’s learning plan, supporting optimal development throughout the residency year.  

PGY2 residency programs build upon Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency training to develop pharmacist practitioners with knowledge, skills, and abilities as defined in the educational competency areas, goals, and objectives for advanced practice areas. Residents who successfully complete PGY2 residency programs are prepared for advanced patient care or other specialized positions, and board certification in the advanced practice area, if available. 

Program Requirements

The resident must meet the following requirements for employment at Corewell Health William Beaumont University Hospital as the PGY-2 infectious diseases pharmacy resident: 

• Licensed pharmacist or eligible for licensure in the State of Michigan (including controlled substance license) 
• Successful completion of a PGY-1 ASHP accredited residency 

PGY2 infectious diseases pharmacy residency criteria for certificate 

• Deliver pharmacy noon conference presentation (1) 
• Deliver William Beaumont University Hospital pharmacy grand rounds (1) 
• Develop and deliver a one-hour accredited CE presentation (1) 
• Deliver ID fellow didactic lectures (2) 
• Successfully complete a formulary review (1) 
• Create or revise an anti-infective guideline/protocol (1) 
• Assist with creation of hospital antibiograms 
• Complete all scheduled journal club presentations (4) 
• Present MUE at a regional or national meeting 
• Present research project at a regional or national meeting 
• Submit new project idea to Residency Project Subcommittee 
• Complete final MUE research project manuscript with submission to and approval of Residency Project Subcommittee (final score of SP or ACH) 
• Obtain and/or maintain active Basic Life Support (BLS) and Advanced Cardiac Life Support (ACLS) certification for duration of residency 
• Complete the on-call service requirements (score of SP or ACH on all objectives in final On-Call Learning Experience evaluation) 
• Completion of PGY2 ID Appendix Core Areas 
• Upload all pertinent residency documents to PharmAcademic and in the PGY2 Shared Drive 
• No program objective with a final score of Needs Improvement (NI) 
• A mark of Achieved for Residency (ACHR) on ≥ 90% of program objectives (minimum of 34 of 37 objectives)

The PGY2 infectious diseases residency program can be structurally divided into 3 components; individual learning experiences (required and elective), longitudinal learning experiences, and weekend staffing. Non-longitudinal learning experiences are generally one calendar month in duration. Our program strives to maximize individual growth and development during the year through the use of our advisor program. 

The PGY2 ID resident will complete 8 required learning experiences, 7 longitudinal required learning experiences, and 3 elective learning experiences. Any required or elective learning experience may be repeated a second time as an elective (with the exception of microbiology/infection prevention and epidemiology). The sequence of learning experiences is dependent upon preceptor availability and resident requests for particular learning experiences prior to midyear clinical meeting. Additionally, the infectious diseases consult service, and the microbiology/infection prevention and epidemiology learning experiences are scheduled prior to December. The PGY2-ID resident will utilize the month of December for research purposes. 

• Orientation (1 month)
• Infectious diseases consult -1 (1 month)
• Infectious diseases consult -2 (1 month)
• Antimicrobial stewardship – 1 (1 month)
• Antimicrobial stewardship -2 (1 month)
• Microbiology (3 weeks) and infection prevention (1 week) – 1 month  
• Critical care (medical or surgical) – 1 month  
• Immunocompromised population (hematology-oncology or solid organ transplant) – 1 month 

• HIV clinic (12 months)
• Antimicrobial stewardship metrics and data analysis (12 months)
• Antimicrobial stewardship and formulary management (12 months)
• MUE Research Project  (12 months)
• On-call service (12 months)
• Staffing  (12 months)
• Continuing Education Lecture (2. 5 months) 

• Emergency medicine (1 month)
• Pediatric infectious diseases (1 month)
• Antimicrobial stewardship - Corewell Health (1 month)
• Antimicrobial stewardship – 3 (1 month)
• Infectious Diseases Consult – 3  (1 month) 

Christine Yost, PharmD, BCIDP
Clinical pharmacy specialist | Infectious diseases
Program director, PGY2 infectious diseases pharmacy residency
Corewell Health William Beaumont University Hospital
Department of pharmaceutical services
3601 West 13 Mile Road
Royal Oak, MI 48073

Noah Wegener, PharmD
PGY2 Infectious Diseases Pharmacy Resident
Corewell Health William Beaumont University Hospital
3601 West 13 Mile Road
Royal Oak, MI 48073